Myriad Genetics (MYGN) Gross Margin (2016 - 2025)
Historic Gross Margin for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to 69.91%.
- Myriad Genetics' Gross Margin fell 3200.0% to 69.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 70.36%, marking a year-over-year increase of 76500.0%. This contributed to the annual value of 69.89% for FY2024, which is 12500.0% up from last year.
- As of Q3 2025, Myriad Genetics' Gross Margin stood at 69.91%, which was down 3200.0% from 71.23% recorded in Q2 2025.
- Myriad Genetics' Gross Margin's 5-year high stood at 74.66% during Q2 2021, with a 5-year trough of 33.24% in Q4 2022.
- Its 5-year average for Gross Margin is 67.0%, with a median of 69.98% in 2023.
- Per our database at Business Quant, Myriad Genetics' Gross Margin tumbled by -382800bps in 2022 and then soared by 299400bps in 2024.
- Quarter analysis of 5 years shows Myriad Genetics' Gross Margin stood at 71.52% in 2021, then plummeted by -54bps to 33.24% in 2022, then increased by 25bps to 41.71% in 2023, then skyrocketed by 72bps to 71.65% in 2024, then fell by -2bps to 69.91% in 2025.
- Its last three reported values are 69.91% in Q3 2025, 71.23% for Q2 2025, and 68.5% during Q1 2025.